Canada Approves First Sleep Apnea Drug for Obesity Patients

Millions of Canadians struggling with both obesity and obstructive sleep apnea finally have a breakthrough treatment option that addresses both conditions simultaneously.

Health Canada recently approved Zepbound (tirzepatide) as the country's first medication specifically designed to treat moderate-to-severe obstructive sleep apnea in adults living with obesity. The drug works alongside diet and exercise changes for people with a body mass index of 30 or higher.

Obstructive sleep apnea affects breathing during sleep when the upper airway becomes blocked, causing repeated interruptions throughout the night. Left untreated, it can lead to serious health problems including cardiovascular disease, Type 2 diabetes, and constant daytime exhaustion.

Dr. Paulette Pillersdorf, a sleep apnea specialist, explains the vicious cycle many patients face. "If you are overweight and you have sleep apnea, it can affect hormones like ghrelin and leptin that make it harder to lose weight," she told CTV News.

The approval came after clinical trials showed remarkable results. Participants taking tirzepatide experienced 63 percent fewer breathing interruptions during sleep compared to those receiving a placebo. Some patients saw their symptoms improve so much that after one year, their condition became mild or even clinically insignificant.

The weight loss connection matters tremendously. Losing just 10 to 15 percent of body weight can decrease apnea scores by as much as 50 percent, moving patients from severe to moderate categories or even into normal ranges.

The Bright Side

While CPAP machines remain the standard treatment, about half of patients struggle to use them consistently. This creates dangerous gaps in care for people who desperately need relief.

Tirzepatide offers hope for the thousands who can't tolerate traditional treatments. It provides another tool in the toolkit rather than replacing existing therapies entirely.

Pillersdorf emphasizes the importance of personalized care. "Every patient is different, and we try to treat each patient on an individual basis depending on what they need," she said.

For people trapped in the exhausting cycle of poor sleep and weight struggles, this new option represents a genuine pathway forward that addresses root causes instead of just managing symptoms.

Better sleep and better health are now within reach for more Canadians than ever before.